Codeine Pharmacogenomics

Codeine Pharmacogenomics is a pharmacogenomic subfield that investigates the genetic determinants of variability in codeine metabolism, efficacy, and safety, particularly focusing on polymorphisms in the CYP2D6 gene and their clinical implications in pediatric populations.

28

Publications

3.4K

Citations

142

Authors

81

Institutions

Publications per year

2017–2026

5

Authors

142

  1. GK
    Gideon Koren

    Hospital for Sick Children, Canada

    4 publications · 422 citations

    4

    h-index

  2. AG
    Andrea Gaedigk

    Children's Mercy Hospital, United States

    4 publications · 1.1K citations

    4

    h-index

  3. BC
    Bruce Carleton

    University of British Columbia, Canada

    3 publications · 116 citations

    3

    h-index

  4. FS
    Folke Sjöqvist

    Karolinska Institutet, Sweden

    3 publications · 352 citations

    3

    h-index

  5. JT
    John T. Callaghan

    Indiana University – Purdue University Indianapolis, United States

    3 publications · 786 citations

    3

    h-index

1–5 of 142

Venues

  1. Clinical Pharmacology & Therapeutics

    CPT · 4 publications · 1.1K citations

    4

    h-index

  2. British Journal of Clinical Pharmacology

    BJCP · 2 publications · 207 citations

    2

    h-index

  3. Therapeutic Drug Monitoring

    2 publications · 140 citations

    2

    h-index

  4. European Journal of Clinical Pharmacology

    2 publications · 330 citations

    2

    h-index

  5. PubMed

    Repository · 2 publications · 82 citations

    2

    h-index

1–5